Press release
MHRA to advise on mHealth app initiative for pharmacovigilance
SMi has confirmed that Phil Tregunno, the MHRA’s Signal Management Unit Manager and WEB-RADR Project Lead, will be speaking at the 9th Social Media in the Pharmaceutical Industry conference. The event takes place on the 18th and 19th of January 2017 in London.
More companies continue to improve initiatives for pharmacovigilance. Recently, the MHRA ran a social media campaign to report suspected side effects for medicines. In line with this, they have partnered with a consortium of world-leading experts from industry, regulatory agencies, and academia to lead the WEB-RADR project.
WEB-RADR is an initiative that seeks to utilise social media and emerging technologies for pharmacovigilance purposes. Phil’s presentation at the conference will give an overview of the project, highlighting updates on the apps they are developing to detect and to report adverse drug reactions as well as ethical guidance and appropriate use.
Phil joins a speaker line-up of senior healthcare marketers and brand managers who will lead presentations and workshops that will provide insights on digital health and social media topics such as social listening, creating web content, digital analytics, patient advocacy, mobile apps, plus much more.
For more updates on the conference, follow SMi Group on @smipharm and join the conversation using #pharmasocialmedia on Twitter.
Social Media in the Pharmaceutical Industry
18 & 19 January 2017
Holiday Inn Kensington Forum, London, UK
http://www.social-media-pharma.com/openPR
---end ---
Contact Information:
For sponsorship and exhibition queries please contact Alia Malick at amalick@smi-online.co.uk. For delegate queries please contact Matthew Apps at mapps@smi-online.co.uk. For media queries please contact Honey de Gracia at hdegracia@smi-online.co.uk.
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
1 Westminster Bridge Road, SE1 7XW
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release MHRA to advise on mHealth app initiative for pharmacovigilance here
News-ID: 382902 • Views: …
More Releases from SMi Group
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference
The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation.
Industry leaders will uncover the…
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK.
With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading…
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022.
With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and…
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week.
With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman.
The…
More Releases for MHRA
MHRA, Pfizer, Autolus and Tusk Theraputics Sign Up for Immuno-Oncology Conferenc …
SMi Reports: Industry leaders MHRA, Pfizer, Autolus, Tusk Therapeutics, KCL, Boehringer Ingelheim and more are amongst the latest organisations to register for Immuno-Oncology 2018 (http://www.immuno-oncology-conference.com/openpr)
There’s just 2 weeks until SMi’s Immuno-Oncology conference commences in London on the 26th and 27th September. With limited places left, interested attendees are urged to book soon to avoid missing out on joining an international gathering of immuno-therapy experts at this highly-anticipated conference.
Recent Confirmed Attendees…
Talks from the MHRA, Innovate UK, Plasticell and more
The lengthening shadow of increase in health spending in the coming years is sharpening the minds of legislators, regulators and payers alike. The growing time-to-market, the rising costs in development of novel medicines, as well as the more basic drive to be ‘ahead of the game’, forces the industry and the legislators to rethink basic postulates of drug development.
The global regulatory environment is undergoing major reshape, allowing patients early access…
SMi’s Injectable Drug Delivery Releases an Exclusive Interview by NIBSC-MHRA
SMi are delighted to have interviewed our speaker Maxime Gaillot, Senior Device Engineer, Roche, for Injectable Drug Delivery!
Maxime Gaillot works for Roche since 2011. He has 15 years’ experience in the medical device and polymer industry. After some years, in the plastic closure industry, Maxime started his career in the Medical Device industry at Novartis. He worked on the development of a dual chamber pen injector and an electronic reusable…
MHRA Update: Regulatory Considerations for The Registration of New Antibacterial …
Taking place in London on 19th and 20th March 2018, the theme for SMi’s 20th annual conference on Superbugs and Superdrugs is to tackle the scientific, regulatory and economic challenges to combat AMR.
Highlights will include an exclusive keynote address from the MHRA when SMi Group welcomes the expertise of Mair Powell to provide regulatory guidance on the registration of new antibacterial agents.
Dr. Powell is a member of the EMA’s Infectious…
MHRA to Open 10th Annual European Summit on Pre-Filled Syringes
The Medicines and Healthcare Products Regulatory Agency present an opening keynote address at SMi’s 10th annual Pre-Filled Syringes Europe conference and exhibition next January.
SMi Group will welcome the expertise of Elizabeth Baker, Group Manager Licensing Division, MHRA, when she presents an opening keynote address at the 10th annual Pre-Filled Syringes Europe conference taking place on 17th and 18th January 2018 in Central London.
The upcoming talk will offer attendees with new…
MHRA & FDA to explore In Vitro Diagnostics regulations in the EU & USA
The 3rd In Vitro Diagnostics conference for SMi Group will take place in London on the 14th & 15th June 2017.
Aimed at Managers/Heads and Directors of Regulatory Affairs, In Vitro Diagnostics, Clinical Affairs and Quality Assurance, IVDs 2017 will provide regulatory updates and key industry feedback from leading IVD manufacturers within this complex and ever-changing landscape.
Through a series of presentations from handpicked industry experts and Notified Bodies, the 2017…
